LONGECITY

Coming up on the Longecity podcast is an interview with SENS Vice President of Research, Dr Matthew O'Connor.

 

SENS is part of our Longecity affiliate lab program and this is sure to be an interesting discussion about current research projects and future ambitions. We last interviewed Dr. O'conner 5 years ago where he talked about the MitoSENS mitochondrial research project.

 

Here's Dr. O'Connor's Bio from the SENS website:

 

Matthew was awarded his Master's degree at Northwestern Medical in 1999 for his work studying behavioral neuroscience in aged rodents. In 2005, at Baylor College of Medicine he received a PhD in Biochemistry for his work on proteins that regulate human telomeres. Postdoctoral research includes work at UC Berkeley on muscle stem cells and aging. Since 2010, Dr. O'Connor has headed up the MitoSENS project at the research center in Mountain View, California. His research is focused on "allotopic expression" of mitochondrial genes where his team is engineering mitochondrial genes to be expressed from the nucleus and targeted to the mitochondia. Since 2012 Dr. O'Connor has had broad oversight over many areas of research at SRF. Matthew O'Connor is passionate about performing basic research to combat the diseases and disabilities of aging.

Edited by Mind, 31 August 2018 - 05:52 PM.

This podcast is now available: https://www.longecity.org/podcast/

 

If you were wondering how MitoSENS was progressing, you will want to check this one out. Dr. O'Connor explains a bit of the technical aspects. In the last 2 or 3 minutes he discusses current mitochondrial "rescue" efforts with supplements. If you take NAD precursors or targeted anti-oxidants, I think you will find it interesting.

Has Longecity considered publishing the podcasts on Spotify (or even YouTube for that matter)? They might get more traffic that way, and it would definitely make listening more accessible for a lot of people